Proof of concept of an experimental prototype for the prevention of parastomal hernia.

Autor: García-Manzanares ME; Servicio de Cirugía General, Aparato Digestivo y Trasplante de Órganos Abdominales, Hospital Universitario 12 de Octubre, Madrid, Spain.; Care Research Group (Invecuid), 12 de Octubre Hospital Institute of Health Research (imas12), Madrid, Spain., Zaragoza-García I; Department of Nursing, Faculty of Nursing, Physiotherapy and Podology, Complutense University of Madrid, Madrid, Spain. izaragoz@ucm.es.; Care Research Group (Invecuid), 12 de Octubre Hospital Institute of Health Research (imas12), Madrid, Spain. izaragoz@ucm.es., Avilés-Escudero M; 12 de Octubre Hospital Institute of Health Research (imas12), Madrid, Spain., Alonso-Cortés Fradejas B; iPhysio Research Group, Faculty of Health Sciences, Universidad de León, 24401, Ponferrada, León, Spain.
Jazyk: angličtina
Zdroj: Updates in surgery [Updates Surg] 2024 Sep; Vol. 76 (5), pp. 1997-2009. Date of Electronic Publication: 2024 May 27.
DOI: 10.1007/s13304-024-01898-0
Abstrakt: Purpose: The aim of this study was to analyse the complications and problems associated with the use of an experimental prototype designed for the prevention of parastomal hernia (PSH), one of the most frequent complications in ostomates.
Methods: A single-centre, non-comparative, proof-of-concept interventional pilot study of an experimental prototype designed to be used in conjunction with an abdominal compression binder to prevent PSH was conducted. The "Ostomy Fixation Device for Hernia Prevention" (patent P201531826) is a semi-rigid ostomy protector, to be used in conjunction with a compression binder. It is designed to adapt to the dimensions of standard ostomy bags from different brands and serves to transmit, in a localised manner, the support coming from the compression binder in the peristomal area without putting pressure on the collection bag. The main outcome measures were efficacy, safety, and patient-users' opinion/perception.
Results: Ten patients were studied for 12 months. Mean age was 61 years (± 11.59), 70% (7) were male, 80% (8) ostomised for colorectal cancer, 90% (9) underwent planned surgery and 80% (8) had a colostomy.
Efficacy: the incidence of HPE was 10% (1).
Safety: no participant experienced pain, discomfort, itching, stinging, leakage, pouch detachment, allergy to components, or injury to the stoma or peristomal skin due to rubbing or pressure. 90% (n = 9) were considered "very satisfied" or "satisfied" with the device.
Conclusions: An innovative device designed in collaboration between healthcare professionals and end-users has been shown to be safe and effective in reducing PSH in the group of ostomates studied.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: